Search - tctmd.com

Displaying 181 - 200 of 397

Sort: Relevancy | Date

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

News Conference News TCT 2015

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

October 12, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Industry News

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

October 05, 2015

News Daily News

新型生物可吸收聚合物 SES 的良好结局持续 2 年

Yael L. Maxwell

October 02, 2015

News Daily News

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

Yael L. Maxwell

October 02, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Daily News

OPTIMAX：生物相容性钴铬支架的首例人类结果前景看好

Yael L. Maxwell

September 14, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Daily News

SES 骨折与长期结局恶化相关

August 31, 2015

News Daily News

SES Fracture Linked to Worse Long-term Outcomes

August 31, 2015

News Daily News

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

August 27, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Daily News

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

Yael L. Maxwell

August 26, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

Salynn Boyles

July 30, 2015

Advertisement

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

Novel Devices Present New Treatment Options for STEMI

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

新型生物可吸收聚合物 SES 的良好结局持续 2 年

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

OPTIMAX：生物相容性钴铬支架的首例人类结果前景看好

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

ABSORB Trials Pit BRS Against Second-Generation DES

SES 骨折与长期结局恶化相关

SES Fracture Linked to Worse Long-term Outcomes

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

COMPARE:5 年时 EES 的疗效仍优于 PES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content